Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
- PMID: 36207567
- PMCID: PMC9546418
- DOI: 10.1007/s10875-022-01372-9
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Conflict of interest statement
A. Bolze and E.T.C. are employees of Helix. The other authors declare no competing interests.
Figures
References
-
- Tenforde MW, Self WH, Gaglani M, Ginde AA, Douin DJ, Talbot HK, et al. Effectiveness of mRNA vaccination in preventing COVID-19-associated invasive mechanical ventilation and death - United States, March 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:459–465. doi: 10.15585/mmwr.mm7112e1. - DOI - PMC - PubMed
-
- Rosenblum HG, Gee J, Liu R, Marquez PL, Zhang B, Strid P, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis. 2022;802–12. Available from: 10.1016/s1473-3099(22)00054-8. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
